20 results
8-K
EX-2.1
IKNA
Ikena Oncology Inc
7 Aug 23
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
8:02am
of whether they are classified as exempt or non-exempt for purposes of the Fair Labor Standards Act, as amended and any similar state law. The Company … employee, applicant for employment, or consultant of the Company.
(o) The Company currently classifies and has properly classified each of its employees
10-K
mboi06a0zmwl4zigcms3
17 Mar 22
Annual report
6:31am
10-Q
mldb8ddz
13 May 21
Quarterly report
4:15pm
8-K
EX-3.1
lrfhrdv8oql521nv
30 Mar 21
Departure of Directors or Certain Officers
12:00am
424B4
auo1i juao0hmpg6
26 Mar 21
Prospectus supplement with pricing info
5:04pm
S-1/A
EX-10.3
1rb0gvz00r1pia5x8 v7
22 Mar 21
IPO registration (amended)
8:51am
S-1/A
EX-3.3
zgkp2n
22 Mar 21
IPO registration (amended)
8:51am
S-1/A
a82c e5tvos
22 Mar 21
IPO registration (amended)
8:51am
S-1
39q2m 33k4rc
5 Mar 21
IPO registration
2:59pm
DRS/A
npm85uvrw1aa7 kn
11 Feb 21
Draft registration statement (amended)
12:00am
DRS
k23my7sqeofn1
8 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next